Lotus Eye Hospital & Institute Ltd.
| BSE: 532998 | Sector: Health care |
| NSE: LOTUSEYE | ISIN Code: INE947I01017 |
| BSE 00:00 | 25 Sep | 29.00 |
1.30 (4.69%) |
OPEN
29.00 |
HIGH
29.00 |
LOW
29.00 |
| NSE 00:00 | 25 Sep | 29.60 |
0.10 (0.34%) |
OPEN
29.00 |
HIGH
29.95 |
LOW
28.65 |
| OPEN | 29.00 |
| PREVIOUS CLOSE | 27.70 |
| VOLUME | 500 |
| 52-Week high | 39.85 |
| 52-Week low | 16.65 |
| P/E | |
| Mkt Cap.(Rs cr) | 60 |
| Buy Price | 28.70 |
| Buy Qty | 100.00 |
| Sell Price | 30.30 |
| Sell Qty | 100.00 |
Lotus Eye Hospital & Institute Ltd. (LOTUSEYE) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 489.45 | 4.05 | 0.83 | 3211.14 |
| Dr Reddy's Labs | 5114.05 | 89.60 | 1.78 | 2937.70 |
| Cipla | 770.20 | 37.40 | 5.10 | 2318.17 |
| Aurobindo Pharma | 771.90 | 28.55 | 3.84 | 1872.74 |
| Cadila Health. | 385.60 | 9.55 | 2.54 | 1412.90 |
| Divi's Lab. | 3061.45 | 40.20 | 1.33 | 1372.71 |
| Glenmark Pharma. | 482.80 | 28.70 | 6.32 | 1354.55 |
| Alkem Lab | 2799.90 | -31.20 | -1.10 | 1264.42 |
| Alembic Pharma | 955.10 | 20.75 | 2.22 | 969.40 |
| Torrent Pharma. | 2719.00 | 70.00 | 2.64 | 938.51 |
| P & G Health Ltd | 4887.65 | 54.40 | 1.13 | 838.72 |
| Lupin | 997.80 | 18.25 | 1.86 | 727.55 |
| Ipca Labs. | 2069.10 | 3.20 | 0.15 | 652.46 |
| Abbott India | 16206.65 | 238.60 | 1.49 | 592.93 |
| Fortis Health. | 137.25 | 1.10 | 0.81 | 513.33 |
| Pfizer | 4918.30 | 44.40 | 0.91 | 509.13 |
| Natco Pharma | 885.55 | 33.35 | 3.91 | 474.50 |
| Apollo Hospitals | 2030.30 | 81.65 | 4.19 | 470.30 |
| Granules India | 375.75 | 15.15 | 4.20 | 444.07 |
| Ajanta Pharma | 1551.10 | -11.25 | -0.72 | 441.13 |
Quick Links for Lotus Eye Hospital & Institute:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
